Pharmexa has been informed about two objections sent to the Danish Commerce and Companies Agency regarding the legality of the resolutions adopted at the Ordinary General Meeting on April 28, 2009 and the Extraordinary General Meeting on May 5, 2009. Pharmexa disagrees with the objections and find them unfounded. As a result of the objections the registration of the resolutions may be delayed. Hørsholm, May 13, 2009 Achim Kaufhold Chief Executive Officer Additional information: Claude Mikkelsen, Senior Vice President, Finance & Investor Relations, tel +45 4516 2525 or +45 4060 2558
Registration of resolutions adopted at Pharmexa's Ordinary General Meeting and Extraordinary General Meeting
| Source: Affitech A/S